On this page
Ajovy
fremanezumab-vfrm
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Ajovy
Proper name
fremanezumab-vfrm
Licence type
351(a)
BLA number
761089
Applicant
Teva Branded Pharmaceutical Products R&D, Inc.
Center
CDER
Presentations
2
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 225MG/1.5ML | Injection | Subcutaneous | Pre-Filled Syringe | Rx | September 14, 2018 |
| 225MG/1.5ML | Injection | Subcutaneous | Autoinjector | Rx | January 27, 2020 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |